Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8106632 | 0.79 | GAA (0.46) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL6313348 | 0.73 | GAA (0.48) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL8780934 | 0.69 | GAA (0.61) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL11256862 | 0.68 | CYP1A2 (0.45) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL11204137 | 0.67 | GAA (0.40) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL11098013 | 0.67 | GAA (0.40) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL10859355 | 0.67 | GAA (0.63) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL8676026 | 0.67 | GAA (0.63) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL10845469 | 0.67 | GAA (0.46) | GAACYP1A2ALDH1A1CDK1MAPT | |
| SCHEMBL8167976 | 0.67 | GAA (0.43) | GAACYP1A2ALDH1A1CDK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7638506-B2 | cationic surfactants; wear resistance; kneading, extrusion; sustained release | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| US-20050250648-A1 | Granular agricultura-chemical composition | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-1498030-A1 | GRANULAR AGRICULTURAL-CHEMICAL COMPOSITION | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-01-19 | — | — | EP | disclosed |
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250648-A1 | Granular agricultura-chemical composition | PRKG1, PRKAG2, AGK | GAA 98/4885CYP1A2 3877/4885ALDH1A1 3414/4885 |
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | GAA 288/4885CYP1A2 47/4885ALDH1A1 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.